| Dr Sawsan Amireh, MD | |
|
1701 E 23rd Ave, Hutchinson, KS 67502-9907 | |
| (620) 665-2000 | |
| Not Available |
| Full Name | Dr Sawsan Amireh |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 13 Years |
| Location | 1701 E 23rd Ave, Hutchinson, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548652514 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 04-42694 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hutchinson Regional Medical Center Inc | Hutchinson, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hutchinson Regional Medical Center Inc | 0648181198 | 53 |
News Archive
Parkinson's disease (PD) is a devastating and incurable disease that causes abnormal poverty of movement, involuntary tremor, and lack of coordination. A technique called deep brain stimulation (DBS) is sometimes used to improve motor symptoms in patients with advanced disease. Now, a study published by Cell Press in the October 20 issue of the journal Neuron describes a new and more effective DBS paradigm that makes real-time adjustments in response to disease dynamics and progression and may be better for managing symptoms of advanced PD.
Eczema caused by defects in the skin could reduce the risk of developing skin cancer, according to new research by King's College London. The immune response triggered by eczema could help prevent tumour formation by shedding potentially cancerous cells from the skin.
Scientists at the Center for Infection and Immunity in the Columbia University Mailman School of Public Health have developed the first diagnostic platform that can simultaneously screen for all known human pathogenic bacteria as well as markers for virulence and antibiotic resistance.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain today announced that it has received CE Mark approval (Conformite Europeenne) for the Zalviso device.
Politico: "Congress completed its work Thursday night on the broadest social legislation in almost a half-century, as the House capped the year-long legislative saga over health reform by signing off on a package of fixes to the newly minted law. In the end, the titanic battle over remaking the American health care system drew to a close on a pair of votes drained of suspense - after the Senate approved the clean-up bill earlier Thursday. The House approved the clean-up bill, 220 to 207" (Budoff Brown, 3/25).
› Verified 8 days ago
| Entity Name | Hutchinson Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972605285 PECOS PAC ID: 0648181198 Enrollment ID: O20040119000578 |
News Archive
Parkinson's disease (PD) is a devastating and incurable disease that causes abnormal poverty of movement, involuntary tremor, and lack of coordination. A technique called deep brain stimulation (DBS) is sometimes used to improve motor symptoms in patients with advanced disease. Now, a study published by Cell Press in the October 20 issue of the journal Neuron describes a new and more effective DBS paradigm that makes real-time adjustments in response to disease dynamics and progression and may be better for managing symptoms of advanced PD.
Eczema caused by defects in the skin could reduce the risk of developing skin cancer, according to new research by King's College London. The immune response triggered by eczema could help prevent tumour formation by shedding potentially cancerous cells from the skin.
Scientists at the Center for Infection and Immunity in the Columbia University Mailman School of Public Health have developed the first diagnostic platform that can simultaneously screen for all known human pathogenic bacteria as well as markers for virulence and antibiotic resistance.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain today announced that it has received CE Mark approval (Conformite Europeenne) for the Zalviso device.
Politico: "Congress completed its work Thursday night on the broadest social legislation in almost a half-century, as the House capped the year-long legislative saga over health reform by signing off on a package of fixes to the newly minted law. In the end, the titanic battle over remaking the American health care system drew to a close on a pair of votes drained of suspense - after the Senate approved the clean-up bill earlier Thursday. The House approved the clean-up bill, 220 to 207" (Budoff Brown, 3/25).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sawsan Amireh, MD 1701 E 23rd Ave, Hutchinson, KS 67502-9907 Ph: (620) 665-2000 | Dr Sawsan Amireh, MD 1701 E 23rd Ave, Hutchinson, KS 67502-9907 Ph: (620) 665-2000 |
News Archive
Parkinson's disease (PD) is a devastating and incurable disease that causes abnormal poverty of movement, involuntary tremor, and lack of coordination. A technique called deep brain stimulation (DBS) is sometimes used to improve motor symptoms in patients with advanced disease. Now, a study published by Cell Press in the October 20 issue of the journal Neuron describes a new and more effective DBS paradigm that makes real-time adjustments in response to disease dynamics and progression and may be better for managing symptoms of advanced PD.
Eczema caused by defects in the skin could reduce the risk of developing skin cancer, according to new research by King's College London. The immune response triggered by eczema could help prevent tumour formation by shedding potentially cancerous cells from the skin.
Scientists at the Center for Infection and Immunity in the Columbia University Mailman School of Public Health have developed the first diagnostic platform that can simultaneously screen for all known human pathogenic bacteria as well as markers for virulence and antibiotic resistance.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain today announced that it has received CE Mark approval (Conformite Europeenne) for the Zalviso device.
Politico: "Congress completed its work Thursday night on the broadest social legislation in almost a half-century, as the House capped the year-long legislative saga over health reform by signing off on a package of fixes to the newly minted law. In the end, the titanic battle over remaking the American health care system drew to a close on a pair of votes drained of suspense - after the Senate approved the clean-up bill earlier Thursday. The House approved the clean-up bill, 220 to 207" (Budoff Brown, 3/25).
› Verified 8 days ago
Moh'd Al-halawani, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1701 E 23rd Ave, Hutchinson, KS 67502 Phone: 620-513-4800 | |
Naveed Salahuddin, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2101 N Waldron St, Hutchinson, KS 67502 Phone: 620-669-2500 | |
Fadi Estephan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2101 N Waldron St, Hutchinson, KS 67502 Phone: 620-669-2500 Fax: 620-694-2037 | |
Kristin Constance, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2100 N Waldron St Ste 5, Hutchinson, KS 67502 Phone: 620-728-1498 Fax: 620-728-1838 | |
Michael Scott Green, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2101 N Waldron St, Hutchinson, KS 67502 Phone: 620-694-4194 Fax: 620-694-2128 | |
Thoutireddy Krishna Reddy, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2101 N Waldron St, Hutchinson, KS 67502 Phone: 620-669-2500 Fax: 620-669-2501 | |
Humayun Ashraf, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2101 N Waldron St, Hutchinson, KS 67502 Phone: 620-669-2500 Fax: 620-694-2076 |